Enovis (ENOV) Stock
Publicly traded company. Here's the price, business snapshot, and what's worth knowing about Enovis in October 2026.
Enovis Corporation is a medical technology company. It is focused on developing clinically differentiated solutions by manufacturing and distributing high-quality medical devices with a range of products used for reconstructive surgery, rehabilitation, pain management and physical therapy. It operates through two segments: Prevention & Recovery and Reconstructive. The Prevention & Recovery segment provides orthopedic and recovery science solutions, including devices, software, and services across the patient care continuum from injury prevention to rehabilitation after surgery, injury, or from degenerative diseases. The Prevention & Recovery products are marketed under several brand names, such as DJO. The Reconstructive segment provides surgical implant solutions, offering a comprehensive suite of reconstructive joint products for the hip, knee, shoulder, elbow, foot, ankle, and finger and surgical productivity tools. It also operates a Enovis Growth eXcellence business system (EGX).
Enovis (ENOV) Stock Forecast
Analyst price target, next 12 months
$53.17
+150.2% vs today's $21.25
Price range over the last 12 months
In the middle of its 12-month range
Analysts covering Enovis have a consensus 12-month target of $53.17, above the current price of $21.25.
Analyst targets are opinions, not guarantees. Capital at risk. Data as of 27 Oct 2026.
Source: Analyst sentiment is provided by Refinitiv Ltd, a global leader in financial market data with over 40k business clients. Refinitiv Ltd is an independent third party to Nemo. This is not advice.
Sixth Month Growth Performance
Stock Performance Snapshot
Analyst Rating
Analysts recommend buying Enovis Corporation's stock with a target price of $53.17, indicating good potential for growth.
Financial Health
Enovis is performing well with strong profits and revenue, indicating a healthy business outlook.
View more stocks by downloading the app for FREE
It only takes 60 seconds.
Why invest with Nemo?
Zero Commission
Trade stocks, ETFs, and more with zero commission. Keep more of your returns.
Trusted & Regulated
Part of Exinity Group 2015, serving over a million customers globally.
